• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国一家三级医院外科和内科重症监护病房呼吸机相关性肺炎的发病率及转归差异

Differences in incidence and outcome of ventilator-associated pneumonia in surgical and medical ICUs in a tertiary hospital in China.

作者信息

Song Xiaochun, Chen Yongming, Li Xiuhua

机构信息

Intensive Care Unit, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

Clin Respir J. 2014 Jul;8(3):262-8. doi: 10.1111/crj.12036. Epub 2014 Apr 4.

DOI:10.1111/crj.12036
PMID:23763833
Abstract

BACKGROUND

Ventilator-associated pneumonia (VAP) is a common hospital-acquired infection in intensive care units (ICUs). The incidences and outcomes of VAP in a medical ICU (MICU) and a surgical ICU (SICU) were compared.

METHODS

A total of 329 patients admitted to the MICU or SICU who were mechanically ventilated for ≥48 h were included.

RESULTS

The incidence of VAP in the MICU was 25%, with 29.7 cases per 1000 ventilator days, and the incidence of VAP in the SICU was 26.7%, with 27.4 cases per 1000 ventilator days. In the MICU patients without VAP spent 6.0 days on the ventilator and those with VAP spent 8.5 days (P < 0.001); the length of stay (LOS) in the ICU was 9.0 days vs 14.0 days for patients without and with VAP, respectively (P < 0.001). The mortality in the MICU was 34.1% for patients without VAP vs 55.8% for those with VAP (P = 0.012), and 30-day mortalities were 31.8% and 41.9%, respectively (P = 0.228); 60-day mortalities were 34.1% and 53.5%, respectively (P = 0.024). In the SICU, patients without and with VAP were ventilated for 5.0 and 10.0 days, respectively (P < 0.001). The ICU LOS was 7.0 days for patients without VAP vs 15.0 days for patients with VAP (P < 0.001). The mortality rates of VAP-free and VAP-positive patients in the SICU were 38.9% and 54.5%, respectively (P = 0.076). The 30-day mortalities were 36.3% and 43.2% (P = 0.424), and 60-day mortalities were 38.9% and 50.0%, for patients without and with VAP, respectively (P = 0.061).

CONCLUSIONS

These data indicate that VAP prolonged time on ventilator and ICU stay in our institute and increased the mortality in the MICU. There were no differences in incidence of or mortality from VAP in the MICU and SICU.

摘要

背景

呼吸机相关性肺炎(VAP)是重症监护病房(ICU)常见的医院获得性感染。比较了内科ICU(MICU)和外科ICU(SICU)中VAP的发生率及转归情况。

方法

纳入329例入住MICU或SICU且机械通气≥48小时的患者。

结果

MICU中VAP的发生率为25%,每1000个呼吸机日有29.7例,SICU中VAP的发生率为26.7%,每1000个呼吸机日有27.4例。在MICU中,未发生VAP的患者机械通气时间为6.0天,发生VAP的患者为8.5天(P<0.001);未发生VAP和发生VAP的患者在ICU的住院时间分别为9.0天和14.0天(P<0.001)。MICU中,未发生VAP的患者死亡率为34.1%,发生VAP的患者为55.8%(P=0.012),30天死亡率分别为31.8%和41.9%(P=0.228);60天死亡率分别为34.1%和53.5%(P=0.024)。在SICU中,未发生VAP和发生VAP的患者机械通气时间分别为5.0天和10.0天(P<0.001)。未发生VAP和发生VAP的患者在ICU的住院时间分别为7.0天和15.0天(P<0.001)。SICU中未发生VAP和发生VAP的患者死亡率分别为38.9%和54.5%(P=0.076)。30天死亡率分别为36.3%和43.2%(P=0.424),60天死亡率分别为38.9%和50.0%(P=0.061)。

结论

这些数据表明,在我们研究所,VAP延长了机械通气时间和ICU住院时间,并增加了MICU的死亡率。MICU和SICU中VAP的发生率和死亡率无差异。

相似文献

1
Differences in incidence and outcome of ventilator-associated pneumonia in surgical and medical ICUs in a tertiary hospital in China.中国一家三级医院外科和内科重症监护病房呼吸机相关性肺炎的发病率及转归差异
Clin Respir J. 2014 Jul;8(3):262-8. doi: 10.1111/crj.12036. Epub 2014 Apr 4.
2
Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study.泰国一家三级护理中心开展的一项减少呼吸机相关性肺炎教育项目的效果:一项为期4年的研究。
Clin Infect Dis. 2007 Sep 15;45(6):704-11. doi: 10.1086/520987. Epub 2007 Aug 6.
3
Incidence and outcomes of ventilator-associated pneumonia in Japanese intensive care units: the Japanese nosocomial infection surveillance system.日本重症监护病房中呼吸机相关性肺炎的发病率及转归:日本医院感染监测系统
Infect Control Hosp Epidemiol. 2007 Mar;28(3):307-13. doi: 10.1086/511997. Epub 2007 Feb 15.
4
Incidence and risk factors for ventilator-associated pneumonia in the surgical intensive care unit, Siriraj Hospital.诗里拉吉医院外科重症监护病房呼吸机相关性肺炎的发病率及危险因素
J Med Assoc Thai. 2014 Jan;97 Suppl 1:S61-8.
5
Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle.实施一个实时合规仪表板,以通过呼吸机集束方案帮助减少外科重症监护病房的呼吸机相关性肺炎。
Arch Surg. 2009 Jul;144(7):656-62. doi: 10.1001/archsurg.2009.117.
6
Comparison of ventilator-associated pneumonia (VAP) rates between different ICUs: Implications of a zero VAP rate.不同 ICU 间呼吸机相关性肺炎(VAP)发生率的比较:零 VAP 发生率的意义。
J Crit Care. 2012 Feb;27(1):26-32. doi: 10.1016/j.jcrc.2011.05.019. Epub 2011 Jul 6.
7
Efficacy of ventilator-associated pneumonia care bundle for prevention of ventilator-associated pneumonia in the surgical intensive care units of a medical center.呼吸机相关性肺炎护理捆绑方案在医疗中心外科重症监护病房预防呼吸机相关性肺炎的效果。
J Microbiol Immunol Infect. 2015 Jun;48(3):316-21. doi: 10.1016/j.jmii.2013.09.007. Epub 2013 Oct 31.
8
Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.郊区医疗中心重症监护病房患者呼吸机相关性肺炎的结局及归因成本
Crit Care Med. 2003 May;31(5):1312-7. doi: 10.1097/01.CCM.0000063087.93157.06.
9
Economic burden of ventilator-associated pneumonia in a developing country.发展中国家呼吸机相关性肺炎的经济负担。
J Hosp Infect. 2012 Jun;81(2):128-30. doi: 10.1016/j.jhin.2012.03.006. Epub 2012 May 1.
10
Incidence and attributable costs of ventilator-associated pneumonia (VAP) in a tertiary-level intensive care unit (ICU) in northern India.印度北部一家三级重症监护病房(ICU)呼吸机相关性肺炎(VAP)的发生率和可归因成本。
J Infect Public Health. 2015 Mar-Apr;8(2):127-35. doi: 10.1016/j.jiph.2014.07.005. Epub 2014 Oct 28.

引用本文的文献

1
Incidence and risk factors of ventilator-associated pneumonia in the intensive care unit: a systematic review and meta-analysis.重症监护病房中呼吸机相关性肺炎的发病率及危险因素:一项系统评价和荟萃分析
J Thorac Dis. 2024 Sep 30;16(9):5518-5528. doi: 10.21037/jtd-24-150. Epub 2024 Sep 14.
2
Study of the gut microbiome as a novel target for prevention of hospital-associated infections in intensive care unit patients.将肠道微生物群作为预防重症监护病房患者医院感染新靶点的研究。
Acute Crit Care. 2023 Feb;38(1):76-85. doi: 10.4266/acc.2022.01116. Epub 2023 Feb 23.
3
Concordance between the National Healthcare Safety Network (NHSN) Surveillance Criteria and Clinical Pulmonary Infection Score (CPIS) Criteria for Diagnosis of Ventilator-associated Pneumonia (VAP).
国家医疗安全网络(NHSN)监测标准与临床肺部感染评分(CPIS)标准在呼吸机相关性肺炎(VAP)诊断方面的一致性。
Indian J Crit Care Med. 2021 Mar;25(3):296-298. doi: 10.5005/jp-journals-10071-23753.
4
Risk factors for mortality in ICU patients with ventilator-associated pneumonia: impact of bacterial cytotoxicity.重症监护病房中患有呼吸机相关性肺炎患者的死亡风险因素:细菌细胞毒性的影响。
J Thorac Dis. 2018 May;10(5):2608-2617. doi: 10.21037/jtd.2018.04.86.